BioSkepsis vs Elicit

Two fact sheets from our own research, side by side — pricing, platforms, API access and status re-checked by us rather than quoted from the vendors.

The short answer

Free plan: Both have one
Public API: Elicit has one; not confirmed by us for BioSkepsis
Higher Trust score: Elicit — 94 vs 76 for BioSkepsis
Best fit: BioSkepsis: researchers doing systematic literature reviews across many papers · Elicit: Systematic reviews and evidence synthesis where every included paper needs the same fields pulled
Status: Both up at our last check (Oct 15, 2026)

From our own records as of each tool's last check. Anything we have not confirmed is left out rather than guessed. How we verify

BioSkepsisA life-sciences research assistant that searches 40M+ biomedical papers and returns cited, mechanism-level answers.

ElicitLiterature review workflow that extracts data into tables

Side by side

Fact	BioSkepsis	Elicit
Category	Academic Search & Literature Review	Academic Search & Literature Review
Pricing model	Freemium	Freemium
Starts at	—	$49/mo
Public API	Not confirmed	Yes
Trust score	76 / 100	94 / 100
Platforms	Web	Web, API
Company	EFEVRE TECH LTD	Elicit
Launched	—	2021
Last verified	Oct 15, 2026	Oct 15, 2026

What our research says

BioSkepsis

Worth trying if literature review is a real bottleneck in your research — the citation-grounded answers and mechanism-level reasoning go further than a plain search summary. The free Basic tier has a monthly usage cap tight enough that regular users will likely need to upgrade to Plus or Pro within a few sessions.

Pros

searches over 40 million biomedical papers with citations attached
gives mechanism-level reasoning rather than a flat summary
exports full reports to PDF or Word with references included
free tier lets you test the workflow before paying

Cons

free tier's monthly usage cap is limiting for regular research work
pricing is in euros and scales quickly from Plus to Team plans
coverage is limited to life sciences, not a general research tool

Elicit

Elicit is the only one of these tools that treats a literature review as a structured extraction job rather than a chat, which is exactly right for the work. The price assumes you are billing someone else for the hours it saves.

Pros

Column-per-field extraction into a table is the correct shape for review work and rare elsewhere
Free tier is unusually generous: unlimited search, summaries and full-text chat
Every claim links back to the paper it came from
API access is included from the first paid tier rather than sold separately

Cons

The $49 to $169 jump is steep and Scale is priced for institutions, not labs
Free tier's limits on the Research Agent and Reports are not quantified anywhere on the pricing page
Extraction accuracy still needs spot-checking against the source PDF
Coverage is paper-centric, so grey literature and preprint-heavy fields are thinner

Which one fits

Choose BioSkepsis if you need

researchers doing systematic literature reviews across many papers
teams that need citations and traceable reasoning, not just a summary
life-science teams evaluating a hypothesis against existing evidence

Choose Elicit if you need

Systematic reviews and evidence synthesis where every included paper needs the same fields pulled
Researchers screening hundreds of abstracts against defined inclusion criteria
Pharma, policy and academic teams that need an auditable trail back to sources